Showing results (501-510 of 2,484) with videos related to
Sort By:
Pageof 249
Expert Review of Vaccines|July 26, 2012
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine productionEmanuele Montomoli, Baharak Khadang, Simona Piccirella, et al.Expert Review of Vaccines|February 7, 2015
IL-33 isoforms: their future as vaccine adjuvants?Daniel O Villarreal, David B WeinerExpert Review of Vaccines|February 14, 2015
A novel approach for addressing diseases not yielding to effective vaccination? Immunization by replication-competent controlled virusRichard Voellmy, David C Bloom, Nuria VilaboaExpert Review of Vaccines|September 22, 2021
Overcoming scientific barriers in the transition from in vivo to non-animal batch testing of human and veterinary vaccinesRobin H G A van den Biggelaar, Marcel H N Hoefnagel, Rob J Vandebriel, et al.Expert Review of Vaccines|September 22, 2021
A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UKAndrew Vyse, James Campling, Carole Czudek, et al.Expert Review of Vaccines|July 3, 2018
Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysisMingjuan Yin, Lingfeng Huang, Yan Zhang, et al.Expert Review of Vaccines|June 9, 2018
From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccineJohn L Perez, Judith Absalon, Johannes Beeslaar, et al.Expert Review of Vaccines|June 19, 2018
A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impactTalia Pindyck, Jacqueline E Tate, Umesh D ParasharExpert Review of Vaccines|May 2, 2018
Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysisJason K H Lee, Gary K L Lam, Thomas Shin, et al.Expert Review of Vaccines|May 2, 2018
How to evaluate potential non-specific effects of vaccines: the quest for randomized trials or time for triangulation?Christine Stabell Benn, Ane Bærent Fisker, Andreas Rieckmann, et al.Pageof 249